Your browser doesn't support javascript.
loading
Importance of CSF-based Aß clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways.
Elbert, Donald L; Patterson, Bruce W; Lucey, Brendan P; Benzinger, Tammie L S; Bateman, Randall J.
Affiliation
  • Elbert DL; Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, TX, USA. don.elbert@utexas.edu.
  • Patterson BW; Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
  • Lucey BP; Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
  • Benzinger TLS; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO, USA.
  • Bateman RJ; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO, USA.
Commun Biol ; 5(1): 98, 2022 01 27.
Article in En | MEDLINE | ID: mdl-35087179
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Blood-Brain Barrier / Amyloid beta-Peptides / Proteolysis Limits: Humans Language: En Journal: Commun Biol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aging / Blood-Brain Barrier / Amyloid beta-Peptides / Proteolysis Limits: Humans Language: En Journal: Commun Biol Year: 2022 Document type: Article Affiliation country: Country of publication: